QQ客服 官方微博 反馈留言

	A Phase I/II trial of fruquintinib in combination with paclitaxel for second-line treatment in patients with advanced gastric cancer
	Xu R.-H., Zhang D., Shen L., Li J., Huang J., Gong J., Guo W., Zhang Y., Fan S., Li K., Hua Y., Su W.
刊名	Journal of Clinical Oncology
	2017
卷号	35
ISSN号	0732-183X
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3613373
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Xu R.-H., Zhang D., Shen L., Li J., Huang J., Gong J., Guo W., Zhang Y., Fan S., Li K., Hua Y., Su W.. A Phase I/II trial of fruquintinib in combination with paclitaxel for second-line treatment in patients with advanced gastric cancer[J]. Journal of Clinical Oncology,2017,35.
APA	Xu R.-H., Zhang D., Shen L., Li J., Huang J., Gong J., Guo W., Zhang Y., Fan S., Li K., Hua Y., Su W..(2017).A Phase I/II trial of fruquintinib in combination with paclitaxel for second-line treatment in patients with advanced gastric cancer.Journal of Clinical Oncology,35.
MLA	Xu R.-H., Zhang D., Shen L., Li J., Huang J., Gong J., Guo W., Zhang Y., Fan S., Li K., Hua Y., Su W.."A Phase I/II trial of fruquintinib in combination with paclitaxel for second-line treatment in patients with advanced gastric cancer".Journal of Clinical Oncology 35(2017).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。